MediCarbone announced it received an NSF SBIR Phase I award for $273,563 for the design and development of its minimally-invasive orthopedic fracture fixation technology, which uses an intramedullary sleeve and injectable, light-triggered bone cement.

“We are thrilled to have received the NSF Award to further our groundbreaking, carbon-fiber-reinforced polymer application—which will deliver a less-invasive alternative to current intramedullary (IM) nailing techniques,” said Hamid Saadatmanesh, Ph.D, PE, CEO of MediCarbone.

The NSF funds research and education in science and engineering through these awards and grants. In fact, the NSF accounts for about 20 percent of the federal funding that academic institutions receive for basic research.

See the NSF Award details and abstract here.